Get the app
US › Healthcare

Briacell Therapeutics Corp (BCTX)

US · Healthcare · Biotechnology

$3.40-9.81%
Last close · 2026-10-16

Latest quarter · ended 2026-04-30

Revenue
$0
Net profit
$-7.2M
EPS
$-0.99

Key statistics

Market cap
$29.6M
Forward P/E
0.0
P/B
1.49
Book value
$3.32
EPS (TTM)
$-0.92
52-week high
$14.68
52-week low
$2.60
50-day MA
$3.80
200-day MA
$4.01
Beta
1.51

Analyst view

with an average price target of $150.00.

Shareholding

Insiders
0.04%
Institutions
6.39%

Largest institutional holders

FundStake
Cable Car Capital LLC2.49%
Sabby Management LLC0.93%
Iridian Asset Management LLC0.75%
UBS Group AG0.50%
HRT FINANCIAL LLC0.40%
Jane Street Group LLC0.30%
LuminArx Capital Management LP0.17%
NATIONAL BANK OF CANADA /FI/0.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Briacell Therapeutics Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.